Coronary microcirculatory dysfunction after percutaneous coronary intervention: pathogenesis, diagnosis, and

Jin BoYuan1, Wang TingTing2, Hua ChengJun1

  • 1National Regional (Traditional Chinese Medicine) Cardiovascular Diagnosis and Treatment Center, Heart Center of the First Affiliated Hospital of Henan University of Traditional Chinese Medicine, Zhengzhou, Henan, China.

PubMed

Insights

Coronary microvascular dysfunction (CMD) after percutaneous coronary intervention (PCI) causes angina. Understanding CMD pathogenesis, diagnosis, and treatment is crucial for improving PCI outcomes and patient care.

Area of Science:

  • Cardiology
  • Vascular Biology
  • Interventional Cardiology

Background:

  • Coronary microvascular dysfunction (CMD) is a significant cause of recurrent angina after percutaneous coronary intervention (PCI).
  • The underlying causes of post-PCI CMD are complex and often not fully understood, limiting treatment effectiveness.
  • CMD can lead to severe adverse cardiovascular events.

Purpose of the Study:

  • To review the physiological roles of the coronary microcirculation.
  • To summarize recent advancements in understanding the pathogenesis, diagnosis, and treatment of CMD post-PCI.
  • To identify critical research gaps and future directions for CMD management.

Main Methods:

  • Literature review of coronary microcirculation physiology.
  • Synthesis of current research on post-PCI CMD etiology and clinical presentation.
  • Analysis of diagnostic and therapeutic strategies for CMD.

Main Results:

  • CMD is a primary driver of angina following PCI.
  • The complex etiology of post-PCI CMD presents diagnostic and therapeutic challenges.
  • Current understanding of CMD pathogenesis, diagnosis, and treatment requires further investigation.

Conclusions:

  • Further research is essential to address knowledge gaps in CMD post-PCI.
  • Identifying and addressing the complex etiology of CMD is key to improving PCI outcomes.
  • Future research should focus on novel diagnostic and therapeutic approaches for CMD.

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
200
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
205
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
226
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
342
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
325
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
219